Trials / Completed
CompletedNCT06298500
Clinical Performance of HISTOACRYL® LAPFIX - CANNULA for Laparoscopic Inguinal Hernia Repair
Retrospective, Single Center Clinical Study on the Clinical Performance of Histoacryl® Lapfix - Cannula for Laparoscopic Inguinal Hernia Repair
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 443 (actual)
- Sponsor
- Aesculap AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this retrospective study is to identify the incidence of hernia recurrence following the application of Histoacryl® Lapfix - Cannula for laparoscopic mesh fixation in patients undergoing hernia repair surgery. All adult patients who underwent laparoscopic inguinal hernia repair with Histoacryl® Lapfix - Cannula in the period June 2018 - March 2021 at Hospital San Juan de Dios will be analysed. The investigator team will access electronical medical records for the cohort of patients identified.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | hernia repair surgery | In recent years, atraumatic mesh fixation with tissue adhesive has increasingly become the method of choice. It is the recommended mesh fixation method by the International Hernia Society Guidelines. In this study patients with inguinal hernia are treated by placing a prosthetic mesh in one of the layers of the abdominal wall to cover the weakness, the mesh is fixed by Histoacryl LapFix, |
Timeline
- Start date
- 2024-03-15
- Primary completion
- 2025-05-07
- Completion
- 2025-05-07
- First posted
- 2024-03-07
- Last updated
- 2025-08-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06298500. Inclusion in this directory is not an endorsement.